Mercedes
Iñarrairaegui Bastarrica
Consultora Médica
University of Birmingham
Birmingham, Reino UnidoPublicaciones en colaboración con investigadores/as de University of Birmingham (3)
2022
-
Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma
Clinical Cancer Research, Vol. 28, Núm. 12, pp. 2555-2566
2016
-
Long-term impact of liver function on curative therapy for hepatocellular carcinoma: Application of the ALBI grade
British Journal of Cancer, Vol. 114, Núm. 7, pp. 744-750
2015
-
A nssessment of liver function in patients with hepatocellular carcinoma: A new evidence-based approach - The albi grade
Journal of Clinical Oncology, Vol. 33, Núm. 6, pp. 550-558